An oncogenic Ezh2 mutation induces tumors through global redistribution of histone 3 lysine 27 trimethylation

Souroullas, George P, Jeck, William R, Parker, Joel S, Simon, Jeremy M, Liu, Jie-Yu, Paulk, Joshiawa, Xiong, Jessie, Clark, Kelly S +5 more·2016·Nature Medicine

DOI 10.1038/nm.4092

Cited by (212)

Items 101–200 of 212

An EZH2-NF-κB regulatory axis drives expression of pro-oncogenic gene signatures in triple negative breast cancer
Gabrielle Dardis, Jun Wang, Jeremy M. Simon, Gang Greg Wang, Albert S. Baldwin · 2023 · iScience
EZH 2 overexpression in head and neck cancer is related to lymph node metastasis
Julie Cläre Nienstedt, Cornelia Schroeder, Till Sebastian Clauditz, Ronald Simon, Guido Sauter, Adrian Muenscher, Marco Blessmann, Henning Hanken, Christina Pflug · 2017 · Journal of Oral Pathology and Medicine
EZH2/Bcl-2 Coexpression Predicts Worse Survival in Diffuse Large B-cell Lymphomas and Demonstrates Poor Efficacy to Rituximab in Localized Lesions
Yujie Deng, Xiaohui Chen, Chuanzhong Huang, Gang Chen, Fangfang Chen, Jianping Lu, Xi Shi, Cheng He, Zhiyong Zeng, Yanhua Qiu et al. · 2019 · Journal of Cancer
The role of tazemetostat in relapsed/refractory follicular lymphoma
Gottfried von Keudell, Gilles Salles · 2021 · Therapeutic Advances in Hematology
Epigenetic regulation by ASXL1 in myeloid malignancies
Feng‐Chun Yang, Joel Agosto-Peña · 2023 · International Journal of Hematology
Gain-of-function mutations in the catalytic domain of DOT1L promote lung cancer malignant phenotypes via the MAPK/ERK signaling pathway
Jiayu Zhang, Ting Yang, Mei Han, Xiaoxuan Wang, Weiming Yang, Ning Guo, Yong Ren, Wei Cui, S. Li, Yongshan Zhao et al. · 2023 · Science Advances
Pathogenic Impacts of Dysregulated Polycomb Repressive Complex Function in Hematological Malignancies
Satoshi Kaito, Atsushi Iwama · 2020 · International Journal of Molecular Sciences
Alterations of Histone Modifications in Cancer
Amir Hosseini, Saverio Minucci · 2018 · Elsevier eBooks
Polycomb and Trithorax Group Proteins: The Long Road from Mutations in Drosophila to Use in Medicine
Darya Chetverina, Д. В. Ломаев, Maksim Erokhin · 2020 · Acta Naturae
SWI/SNF Chromatin Remodeling Enzymes in Melanoma
Megan R. Dreier, Ivana L. de la Serna · 2022 · Epigenomes
Ezh2Y641F mutations co-operate with Stat3 to regulate MHC Class I antigen processing and alter the tumor immune response in melanoma
Sarah M. Zimmerman, S. Nixon, Pei-Yu Chen, L. Raj, Sofia R. Smith, R. Paolini, Phyo Nay Lin, G. Souroullas · 2022 · Oncogene
Coupling Fluorescence-Activated Cell Sorting and Targeted Analysis of Histone Modification Profiles in Primary Human Leukocytes
Jeannie M. Camarillo, Suchitra Swaminathan, Nebiyu Ali Abshiru, Jacek W. Sikora, Paul M. Thomas, Neil L. Kelleher · 2019 · Journal of the American Society for Mass Spectrometry
Identification and Assessments of Novel and Potent Small-Molecule Inhibitors of EED–EZH2 Interaction of Polycomb Repressive Complex 2 by Computational Methods and Biological Evaluations
Kongkai Zhu, Daohai Du, Rui Juan Yang, Hongrui Tao, Hua Zhang · 2019 · Chemical and Pharmaceutical Bulletin
Causes, effects, and clinical implications of perturbed patterns within the cancer epigenome
Urszula Oleksiewicz, Marta Machnik · 2020 · Seminars in Cancer Biology
HDAC2- and EZH2-Mediated Histone Modifications Induce PDK1 Expression through miR-148a Downregulation in Breast Cancer Progression and Adriamycin Resistance
Yun-Xia Xie, Zhumei Shi, Ying-Chen Qian, Chengfei Jiang, Wenjing Liu, Bingjie Liu, Bing‐Hua Jiang · 2022 · Cancers
EZH2 W113C is a gain-of-function mutation in B-cell lymphoma enabling both PRC2 methyltransferase activation and tazemetostat resistance
Liping Chu, Dongxia Tan, Meimei Zhu, Yu-Xiu Qu, Xin Ma, Bao‐Liang Song, Wei Qi · 2023 · Journal of Biological Chemistry
EZH2 inhibition stimulates repetitive element expression and viral mimicry in resting splenic B cells
Seung J. Kim, Patti K. Kiser, Samuel Asfaha, Rodney P. DeKoter, Frederick A. Dick · 2023 · The EMBO Journal
Murine models of germinal center derived-lymphomas
Parham Ramezani-Rad, Robert C. Rickert · 2017 · Current Opinion in Immunology
BET-bromodomain and EZH2 inhibitor–treated chronic GVHD mice have blunted germinal centers with distinct transcriptomes
Michael C. Zaiken, Ryan P Flynn, Katelyn G. Paz, Stephanie Y. Rhee, Sujeong Jin, Fathima A. Mohamed, Asim Saha, Govindarajan Thangavelu, Paul M.C. Park, Matthew L. Hemming et al. · 2022 · Blood
Discovery of selective activators of PRC2 mutant EED-I363M
Junghyun L. Suh, Kimberly D. Barnash, Tigran M. Abramyan, Fengling Li, Juliana The, Isabelle A. Engelberg, Masoud Vedadi, Peter J. Brown, Dmitri Kireev, C.H. Arrowsmith et al. · 2019 · Scientific Reports
Know when to fold ‘em: Polycomb complexes in oncogenic 3D genome regulation
Emma J. Doyle, Lluís Morey, Eric Conway · 2022 · Frontiers in Cell and Developmental Biology
lncRNAs-EZH2 interaction as promising therapeutic target in cutaneous melanoma
Michał Woźniak, Małgorzata Czyż · 2023 · Frontiers in Molecular Biosciences
The Status and Prospects of Epigenetics in the Treatment of Lymphoma
Jiaxin Liu, Jianan Li, Hongyu Wu, Panpan Liu · 2022 · Frontiers in Oncology
EZH2 Overexpression in Multiple Myeloma: Prognostic Value, Correlation With Clinical Characteristics, and Possible Mechanisms
Scott Ryan Goldsmith, Mark Aaron Fiala, Julie O’Neal, George P. Souroullas, Wael Toama, Ravi Vij, Mark A. Schroeder · 2019 · Clinical Lymphoma Myeloma & Leukemia
Molecular Diagnostic Review of Diffuse Large B-Cell Lymphoma and Its Tumor Microenvironment
Robert M. Ta, David T. Yang, Christian Hirt, Thomas J. Drago, Richard Flavin · 2022 · Diagnostics
Modeling the crosstalk between malignant B cells and their microenvironment in B-cell lymphomas: challenges and opportunities
Baptiste Brauge, Elise Dessauge, Florent Creusat, Karin Tarte · 2023 · Frontiers in Immunology
Human B Lymphomas Reveal Their Secrets Through Genetic Mouse Models
Noushin Mossadegh‐Keller, Gabriel Brisou, Alicia Beyou, Bertrand Nadel, Sandrine Roulland · 2021 · Frontiers in Immunology
Mouse Models of Germinal Center Derived B-Cell Lymphomas
Stefanie N. Meyer, Sanjay Koul, Laura Pasqualucci · 2021 · Frontiers in Immunology
Management of indolent B-cell Lymphomas: A review of approved and emerging targeted therapies
Elizabeth Smyth, Chan Yoon Cheah, John Francis Seymour · 2023 · Cancer Treatment Reviews
Novel molecular classifications of DLBCL
Sydney Dubois, Fabrice Jardin · 2018 · Nature Reviews Clinical Oncology
Stem cell characteristics promote aggressiveness of diffuse large B-cell lymphoma
Kung‐Chao Chang, Ruo-Yu Chen, Yu-Chu Wang, Liang‐Yi Hung, Leonard Jeffrey Medeiros, Yaping Chen, Tsai‐Yun Chen, Jui‐Chu Yang, Po‐Min Chiang · 2020 · Scientific Reports
The PRC2 complex epigenetically silences GATA4 to suppress cellular senescence and promote the progression of breast cancer
Wenqian Yu, Xiaona Lin, Shuai Leng, Yiming Hou, Zhiqiao Dang, Shishan Xue, Na Li, Fengquan Zhang · 2024 · Translational Oncology
Molecular Pathogenesis of Follicular Lymphoma: From Genetics to Clinical Practice
Cristina López, Pablo Mozas, Armando López‐Guillermo, Sı́lvia Beà · 2022 · Hemato
Epigenomic Consequences of Coding and Noncoding Driver Mutations
Xiaosai Yao, Manjie Xing, Wen Fong Ooi, Patrick B. O. Tan, Bin Tean Teh · 2016 · Trends in cancer
The Role of Chromatin-Associated Proteins in Cancer
Kristian Helin, Saverio Minucci · 2016 · Annual Review of Cancer Biology
Novel approach to therapeutic targeting of castration-resistant prostate cancer
Eswar Shankar, Daniel Franco, Omair Iqbal, Victoria El-Hayek, Sanjay Gupta · 2020 · Medical Hypotheses
Epigenetic Regulation of the Non-Coding Genome: Opportunities for Immuno-Oncology
María J. Barrero · 2020 · Epigenomes
Identification of catalytic and non‐catalytic activity inhibitors against PRC2‐EZH2 complex through multiple high‐throughput screening campaigns
Yan Zhou, Daohai Du, Jia Wang, Xiaoqing Cai, Alicia X. Deng, Olivier Nosjean, Jean Albert Boutin, Pierre Renard, Dehua Yang, Cheng Luo et al. · 2020 · Chemical Biology & Drug Design
Vaping and tumor metastasis: current insights and progress
Yibo Xi, Lei Yang, Barbara Ann Burtness, He Wang · 2024 · Cancer and Metastasis Reviews
Multiple regulatory aspects of histone methyltransferase EZH2 in Pb-induced neurotoxicity
Weizhen Xue, Xiaozhen Gu, Yulan Wu, Danyang Li, Yi Xu, Hui-Li Wang · 2017 · Oncotarget
Harnessing lymphoma epigenetics to improve therapies (article not eligible for CME credit)
Haopeng Yang, Michael R. Green · 2020 · Hematology
Identification of Potential Biomarkers for Liver Cancer Through Gene Mutation and Clinical Characteristics
Yunlong Cui, Hua Li, Hongjie Zhan, Tao Han, Yixuan Dong, Caijuan Tian, Yixian Guo, Yan Fang, Dong Dai, Pengfei Liu · 2021 · Frontiers in Oncology
EZH2: a pleiotropic protein
Thomas Burmeister · 2016 · Blood
Harnessing lymphoma epigenetics to improve therapies
Haopeng Yang, Michael R. Green · 2020 · Blood
Reduced H3K27me3 Expression is Common in Nodular Melanomas of Childhood Associated With Congenital Melanocytic Nevi But Not in Proliferative Nodules
Nicolas Macagno, Heather Etchevers, Nausicaa Malissen, Angélique Rome, S. Hesse, S. Mallet, N. Dégardin, Caroline Gaudy‐Marqueste · 2018 · The American Journal of Surgical Pathology
RePhine: An Integrative Method for Identification of Drug Response-Related Transcriptional Regulators
Xujun Wang, Zhengtao Zhang, Wenyi Qin, Shiyi Liu, Cong Liu, Georgi Z. Genchev, Lijian Hui, Hongyu Zhao, Hui Juan Lu · 2021 · Genomics Proteomics & Bioinformatics
Overcoming the therapeutic limitations of EZH2 inhibitors in Burkitt’s lymphoma: a comprehensive study on the combined effects of MS1943 and Ibrutinib
Yurim Jeong, Se Been Kim, Chae Eun Yang, Min Seo Yu, Wan-Su Choi, Young‐Woo Jeon, Jung-Yeon Lim · 2023 · Frontiers in Oncology
The Role of ASXL1/2 and Their Associated Proteins in Malignant Hematopoiesis
Peng Zhang, Mingjiang Xu, Feng‐Chun Yang · 2020 · Current Stem Cell Reports
New molecular tumor markers for endometrial cancer.
Fumitaka Numa, Kenji Umayahara, Yutaka Suehiro, Yoshinori Suminami, Atunori Oga, Kohsuke Sasaki, Hiroyuki Kato · 2001 · PubMed
EZH2 loss promotes gastric squamous cell carcinoma
Mengsha Zhang, Ailing Zhong, Hongyu Liu, Lei Zhao, Y F Wang, Zhenghao Lu, Lanxin Zhang, Xiangyu Pan, Zuoyu Liang, Limin Gao et al. · 2025 · Nature Communications
KDM6 Demethylases Contribute to EWSR1::FLI1-Driven Oncogenic Reprogramming in Ewing Sarcoma
Elisabet Figuerola-Bou, Carla Ríos-Astorch, Enrique Blanco, María Sánchez-Jiménez, Pablo Táboas, Guerau Fernández, Soledad Gómez‐González, Oscar Muñoz, Pol Castellano‐Escuder, Sara Pérez‐Jaume et al. · 2025 · Cancer Research
Stat3-mediated Atg7 expression regulates anti-tumor immunity in mouse melanoma
Sarah M. Zimmerman, Erin Suh, Sofia R Smith, George P. Souroullas · 2024 · Cancer Immunology Immunotherapy
Enhancer of Zeste Homolog 2 Protects Mucosal Melanoma from Ferroptosis via the KLF14-SLC7A11 Signaling Pathway
Haizhen Du, Lijie Hou, Huan Yu, Fenghao Zhang, Ke Tong, Xiaowen Wu, Ziyi Zhang, Kaiping Liu, Xiangguang Miao, Wenhui Guo et al. · 2024 · Cancers
A Cohort Study of the Prognostic Impact of Exon-16 EZH2 Mutations in a Mexican-Mestizo Population of Patients with Diffuse Large B-Cell Lymphoma
Luis Fernando Oñate-Ocaña, Mayra Ponce-Martínez, Lucia Taja-Chayeb, Olga Gutiérrez-Hernández, Alejandro Avilés-Salas, David Cantú-de-León, Alfonso Dueñas-González, Myrna Candelaria-Hernández · 2021 · Revista de investigaci�n Cl�nica
Integrative Multi-Omics Analysis of Oncogenic EZH2 Mutants: From Epigenetic Reprogramming to Molecular Signatures
Julian Aldana, Miranda L. Gardner, Michael A. Freitas · 2023 · International Journal of Molecular Sciences
Ezh2-dependent therapies in bladder cancer: synthetic lethality
Cristina Segovia, Jesús María Paramio · 2017 · Annals of Translational Medicine
Mouse Models of Myeloid Malignancies
Faisal Basheer, George S. Vassiliou · 2020 · Cold Spring Harbor Perspectives in Medicine
Genetic Impairments of PRC2 Activity in Oncology: Problems and Prospects
Darya Chetverina, Д. В. Ломаев, Pavel G Georgiev, Maksim Erokhin · 2021 · Russian Journal of Genetics
Mouse models of diffuse large B cell lymphoma
Areya Tabatabai, Aastha Arora, Svenja Höfmann, Maximilian Jauch, Bastian von Tresckow, Julia Hansen, Ruth Flümann, Ron Daniel Jachimowicz, Sebastian Klein, Hans Christian Reinhardt et al. · 2023 · Frontiers in Immunology
New drugs for new targets in lymphoma
Anas Younes · 2019 · Hematological Oncology
Histone 3 Methyltransferases Alter Melanoma Initiation and Progression Through Discrete Mechanisms
Sara E. DiNapoli, Raúl Martinez-McFaline, Hao Shen, Ashley S. Doane, Alexendar R. Perez, Akanksha Verma, Amanda Simon, Isabel S. Nelson, Courtney A. Balgobin, Caitlin Bourque et al. · 2022 · Frontiers in Cell and Developmental Biology
Generation and characterization of the Eµ-Irf8 mouse model
Zhijun Qiu, Kenneth N. Holder, An-Ping Lin, Jamie Myers, Shoulei Jiang, Karla M. Gorena, Marsha C. Kinney, Ricardo C.T. Aguiar · 2020 · Cancer Genetics
The mechanistic GEMMs of oncogenic histones
Anders M. Lindroth, Yoon Jung Park, Verónica Matía, Massimo Squatrito · 2020 · Human Molecular Genetics
Distinct binding pattern of EZH2 and JARID2 on RNAs and DNAs in hepatocellular carcinoma development
Zhili Wen, Ke He, Meixiao Zhan, Yong Li, Fei Liu, Xu He, Yanli Wei, Wei Zhao, Yu Zhang, Yaqiang Xue et al. · 2022 · Frontiers in Oncology
Epigenetic alteration contributes to the transcriptional reprogramming in T-cell prolymphocytic leukemia
Shulan Tian, Henan Zhang, Pan Zhang, Michael T. Kalmbach, Jeong‐Heon Lee, Tamás Ördög, Paul Joseph Hampel, Timothy G. Call, Thomas Elmer Witzig, Neil E. Kay et al. · 2021 · Scientific Reports
Anticancer chiral and racemic ternary copper(II) complexes: Multiple mechanisms and epigenetic histone methyltransferase enzymes as novel targets
Cheang Wei Chan, Chin Yoong Yong, How Mun Chang, Pei Ying Ng, Fabian Amalraj Davamani, Ebenezer Chitra, Vannajan Sanghiran Lee, Kong Wai Tan, Mohd Jamil Maah, Chew Hee Ng · 2021 · Polyhedron
The cancer epigenome: Non‐cell autonomous player in tumor immunity
Shinichiro Kato, Yuka Maeda, Daisuke Sugiyama, Keisuke Watanabe, Hiroyoshi Nishikawa, Kunihiko Hinohara · 2022 · Cancer Science
Genome-wide Analysis of Histone H3 Lysine 27 Trimethylation Profiles in Sciatic Nerve of Chronic Constriction Injury Rats
Shuhui Chen, Xinpei Gu, Ruidi Li, Shuhong An, Zhaojin Wang · 2023 · Neurochemical Research
Multiomic study of cutaneous T-cell lymphoma reveals single-cell clonal evolution in progression and therapy resistance
Hannah K. Dorando, Jared M. Andrews, Oam U. Khatavkar, Nicholas C. Borcherding, Yulia O. Korshunova, Gabriela Hakeman, Rodrigo Borgiani Panigassi, Phuong MN Vo, Ruei-yuan Tu, Diep Tran et al. · 2026 · Blood
The Emerging Epigenetic Landscape in Melanoma
Robert A. Rollins, Kimberly Hyunjung Kim, Cheng‐Chung Tsao · 2016 · InTech eBooks
Overexpression of interleukin-20 correlates with favourable prognosis in diffuse large B-cell lymphoma
Yi-Sian Lu, Po‐Min Chiang, Yi-Ching Huang, Shiang-Jie Yang, Liang‐Yi Hung, Leonard Jeffrey Medeiros, Yaping Chen, Tsai‐Yun Chen, Ming‐Shi Chang, Kung‐Chao Chang · 2022 · Pathology
BMP‐ACVR1 Axis is Critical for Efficacy of PRC2 Inhibitors in B‐Cell Lymphoma
Dongdong Liu, Zhen Li, Dongxia Tan, Yang An, Liping Chu, Tiancheng Chen, Weijia Li, Ailin Zhou, Ruijie Xiang, Liye Zhang et al. · 2024 · Advanced Science
Misregulation of Histone Methylation Regulators in Cancer
Wen Fong Ooi, Xiaosai Yao, Patrick B. O. Tan, Bin Tean Teh · 2017 · Cancer drug discovery and develogment/Cancer drug discovery and development
Developmental stage and cellular context determine oncogenic and molecular outcomes of Ezh2Y641F mutation in hematopoiesis
Sarah M. Zimmerman, Samantha J. Procasky, Sofia R Smith, Jieyu Liu, Chad Torrice, George P. Souroullas · 2025 · Blood Neoplasia
Multidimensional Roles of EZH2 and Its Therapeutic Potential in Cancer TherapyReview Article
Hui Yong Yin, Jinna Tan, Jiaqian He, Mingfen Li, Hongsheng Lin · 2025 · Life Conflux
Polycomb Repressive Complex 2 in Oncology
Yiran Guo, Yao Yu, Gang Greg Wang · 2023 · Cancer treatment and research
Genomic Drivers in Follicular Lymphoma
Saber Tadros, Michael R. Green · 2019 · Springer eBooks
The role of EZH1 and EZH2 in development and cancer
Chul‐Hwan Lee, Yingying Li, Hanbyeol Kim, Seounghyun Eum, Kyumin Park, Soo Hyun Lee · 2022 · BMB Reports
A goldilocks amount of H3K27me3
Tyler J. Reich, Peter W. Lewis · 2023 · Nature Chemical Biology
A Novel Acetylation-Immune Subtyping for the Identification of a BET Inhibitor-Sensitive Subgroup in Melanoma
Liuying Wang, Liuchao Zhang, Shuang Li, Lei Cao, Kang Li, Weiwei Zhao · 2023 · Pharmaceuticals
Genetic Mouse Models of Lymphomas
Gero Knittel, Hans Christian Reinhardt · 2024 · Methods in molecular biology
Epigenetic landscape of the H3K27me3 mark in macrophages transformed by Theileria annulata
Takaya Sakura, Shahin Tajeri, Zineb Rchiad, Hifzur Rahman Ansari, Abhinav Kaushik, Tobias Mourier, Arnab Pain, Michel Adam Wassef, Gordon Langsley · 2026 · Communications Biology
Allosteric Inhibition of Polycomb Repressive Complex 2 by an EZH2‐Selective Small Molecule Inhibitor
Ting Cao, Dongdong Liu, Haishan Gao, Chenyang Qin, Wen Zhang, Ziyun Lu, Dongxia Tan, Yu-Xiu Qu, Yusong Liu, Zhiran Zou et al. · 2026 · Advanced Science
Epigenetics and One-Carbon Metabolism in Cancer: Mechanisms and Therapeutic Implications
Jacinta Serpa, Joana R. Costa · 2026 · Advances in experimental medicine and biology
In-depth understanding of higher-order genome architecture in orphan cancer
Tianyi Ding, Jixing Zhang, Haowen Xu, Xiaoyu Zhang, Fan Yang, Yibing Shi, Yiran Bai, Jiaqi Yang, Chaoqun Chen, He Zhang · 2023 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
Therapeutic index of targeting select chromatin complexes in human cancer patients
Yuan Gao, Christopher R. Vakoc · 2024 · Current Opinion in Genetics & Development
Melanomics: Comprehensive Molecular Analysis of Normal and Neoplastic Melanocytes
Xuan Tien Steven Nguyen, Ian R. Watson · 2018 · Springer eBooks
Increased EZH2 function in regulatory T cells promotes their capacity to suppress autoimmunity by driving effector differentiation prior to activation
Janneke G. C. Peeters, Stephanie L. Silveria, Merve Özdemir, Srinivas Ramachandran, Michel J.P. DuPage · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
Single Cell Resolution Tracking of Cutaneous T-Cell Lymphoma Reveals Clonal Evolution in Disease Progression
Hannah K. Dorando, Jared M. Andrews, Nicholas C. Borcherding, Chaz C. Quinn, Jennifer A Schmidt, Oam U. Khatavkar, Jahnavi Aluri, Michael T. Harmon, Marcus P. Watkins, Anastasia Frank et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
Connecting the DOT1L: it’s EZH2
Richard Eric Davis · 2025 · Blood
Genomic Applications in Melanoma
Carlos N. Prieto Granada, John Van Arnam, Kabeer Shah, Aleodor A. Andea, Alexander J. Lazar · 2018 · Springer eBooks
Melanomics: Comprehensive Molecular Analysis of Normal and Neoplastic Melanocytes
Xuan Tien Steven Nguyen, Ian R. Watson · 2019 · Springer eBooks
The Role of Epigenetic Dysregulation in Lymphoma Biology
Qing Deng and, Michael R. Green · 2023
EZH2 inhibition stimulates viral mimicry in resting splenic B cells
Seung J. Kim, Patti K. Kiser, Rodney P. DeKoter, Frederick A. Dick · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
Dual targeting of EZH2 and Histone Deacetylases in hematological malignancies promotes transcriptional and metabolic deregulation leading to ferroptosis
Alexandra Bacquelaine Veloso, Thomas Slegers, Jente M. Schoenaker, Sofie Demeyer, Stef Van den Bergh, Margo Aertgeerts, Krista Roberta Verhoeft, Yilke Schoenmaekers, Nienke Meeuws, Ilan Bischops et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
Mutational synergy with CREBBP loss in lymphomagenesis identified through forward insertional mutagenesis in a new DLBCL mouse model
Nathalie Sakakini, Roy Straver, Dhoyazan Azazi, Sarah J. Horton, Ryan J. Asby, Simon E. Richardson, Pedro Madrigal, Elizabeth J. Soilleux, Rachael J. M. Bashford-Rogers, Jeroen de Ridder et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
Developmental Stage and Cellular Context Determine Oncogenic and Molecular Outcomes of Ezh2 Y641F Mutation in Hematopoiesis
Sarah M. Zimmerman, Samantha J. Procasky, Sofia R Smith, Jieyu Liu, Chad Torrice, George P. Souroullas · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
High SRD5A3 expression is correlated with promotion of proliferation and inhibition of apoptosis in B-cell non-Hodgkin lymphoma and suggests a poor prognosis
Shanshan Wei, Jie Sun, Jiahao Wen, Jianing Yu, Yixuan Xuan, Jingyu Huang, Jie Yang, Jianfeng Zhang · 2025 · PLoS ONE
Novel Flavonoid Derivatives Show Potent Efficacy in Human Lymphoma Models
Eugenio Gaudio, Paulina Biniecka, Alberto J. Arribas, Eleonora Cannas, Guido J.R. Zaman, Derya Unutmaz, Francesco Bertoni, Dan F. Stoicescu · 2025 · eJHaem
AEBP2-Directed H3K27me2 Defines a Specific Vulnerability in EZH2-mutant Lymphoma
Daniel Angelov, James Nolan, Gráinne Holland, Darragh Nimmo, Molly Davies, Craig Monger, Eugène Dillon, Marlena Mucha, Cheng Wang, Dáire Gannon et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)